Content about Pseudoephedrine

April 2, 2013

DSN caught up with Greg Bradley — president and CEO of Advantage Consumer Healthcare, a full turnkey solution center for over-the-counter medicines reaching the market — for an overview of the new marketing and sales solution company as it has recently brought to market OraSure Technologies' OraQuick Advance, a take-home HIV test kit that the Food and Drug Administration recently approved for the self-care market, and Westport Pharmaceuticals' Zephrex-D, a pseudoephedrine product with a unique point of differentiation.

April 9, 2014

The Consumer Healthcare Products Association on Tuesday applauded Tennessee state Rep. Tony Shipley, R-Kingsport, after his legislation — H.B. 1257 — passed out of the Tennessee House of Representatives.

March 20, 2014

The Consumer Healthcare Products Association on Wednesday released the results of a recent poll of Missouri voters conducted by GS Strategy Group and supported by CHPA that found a clear majority of state residents oppose proposed legislation that would require a prescription for the purchase of pseudoephedrine.

February 19, 2014

The West Virginia Senate on Tuesday voted 25-to-9 to make pseudoephedrine a Schedule IV prescription drug and exempt medicines that can’t easily be diverted to methamphetamine, according to published reports.

February 18, 2014

This year, ECRM celebrates 20 years of successfully pairing buyers and sellers across the consumer packaged goods industry.

February 6, 2014

West Virginia took one step closer to making pseudoephedrine products prescription-only, as the state's Senate Committee on Health voted Tuesday to move ahead with the proposal, according to an Associated Press report.

January 22, 2014

According to an economic impact analysis released Tuesday by Martin Kennedy, a former professor of economics who spent seven years on the faculty of Middle Tennessee State University, adopting a prescription requirement for pseudoephedrine products in Tennessee would result in an influx of more than 497,000 additional physician office visits at a direct cost of $44.3 million annually.

January 3, 2014

Fruth Pharmacy is seeing a positive response from customers in its efforts to limit the sale of OTC cold and allergy medications that contain pseudoephedrine, according to published reports.

December 10, 2013

Lt. Gov. Ron Ramsey, Tennessee Rep. Tony Shipley, R-Kingsport along with representatives from Food City and the Consumer Healthcare Products Association, announced the expansion of Tennessee's statewide Anti-Smurfing Campaign.

November 20, 2013

Through mid-November, a national registry of over-the-counter drugs considered chemical precursors to methamphetamine prevented more than 16,700 boxes of the drugs from being sold illegally.

November 6, 2013

Rite Aid has stopped selling some cold medicines containing pseudoephedrine at its stores in West Virginia, according to published reports.

November 5, 2013

Acura Pharmaceuticals on Monday announced that Nexafed, its next generation pseudoephedrine with abuse-deterrent technology, will now be stocked by Rite Aid.

September 27, 2013

ScriptPro's Central Pharmacy Management System Point of Sale can now interface with a real-time system for tracking and controlling OTC products that can be used to manufacture methamphetamine.

September 5, 2013

The Consumer Healthcare Products Association joined Indiana Attorney General Greg Zoeller, state Rep. Larry Bucshon, as well as local officials and leaders from the Indiana Pharmacists Alliance, the Indiana Prosecuting Attorneys Council, the Indiana Retail Council and the Community Anti-Drug Coalitions of America, at a press conference to launch the state’s new voluntary retail Anti-Smurfing Campaign.

September 5, 2013

Acura Pharmaceuticals announced a study, published in the September issue of the American Journal of Drug and Alcohol Abuse, that validates the ability of Nexafed to uniquely disrupt the extraction and conversion of pseudoephedrine into methamphetamine.

August 28, 2013

The Consumer Healthcare Products Association on Wednesay applauded Delaware Rep. Rebecca Walker, the Delaware legislature and Gov. Jack Markell for passing and signing House Bill 130, an anti-methamphetamine bill.

August 28, 2013

Fruth Pharmacy is taking up a pseudoephedrine product for nasal congestion designed to deter the manufacturing of methamphetamine at all of its stores, according to published reports.

August 8, 2013

Pennsylvania last month became the 29th state to employ the National Precursor Log Exchange in the fight against the diversion of products containing pseudoephedrine into methamphetamine. State No. 30, Delaware, is expected to sign real-time stop sale technology into law this summer.

July 22, 2013

As many as 62% of Springfield, Mo., residents oppose a proposed law that would require all consumers to obtain a doctor's prescription before buying cold and allergy medicines containing pseudoephedrine, according to a recent poll conducted on behalf of the Consumer Healthcare Products Association Magellan Strategies.

July 15, 2013

Acura Pharmaceuticals on Monday announced a second-generation prototype formulation of its methamphetamine-resistant IMPEDE technology with pseudoephedrine hydrochloride yielded no measurable amount of methamphetamine hydrochloride when processed in the direct conversion or one-pot method.

July 10, 2013

The Consumer Healthcare Products Association on Wednesday applauded the Pennsylvania legislature and Gov. Tom Corbett for passage of House Bill 602, legislation requiring real-time, stop-sale technology to enable retailers to block illegal pseudoephedrine purchases at the point of sale.

June 6, 2013

The Consumer Healthcare Products Association on Thursday applauded the Vermont legislature and Gov. Peter Shumlin for their passage of House Bill 522, which makes Vermont the 27th state to adopt the pseudoephedrine-tracking system known as the National Precursor Log Exchange.

May 31, 2013

Fruth Pharmacy announced their commitment to replace medications containing pseudoephedrine, a nonprescription decongestant that can be used in the illicit manufacture of methamphetamine, with Nexafed, a PSE product formulated with Impede technology that disrupts the extraction and conversion of PSE to meth.

May 30, 2013

Westport Pharmaceuticals announced findings from independent testing of their meth-resistant pseudoephedrine product, Zephrex-D.

© 2014 Drug Store News. All Rights Reserved.